Lung Adenocarcinoma: Correlation between mRNA expression and clinical features
Maintained by TCGA GDAC Team (Broad Institute/Dana-Farber Cancer Institute/Harvard Medical School)
- Overview
+ Introduction
- Summary

Testing the association between 17814 genes and 11 clinical features across 23 samples, statistically thresholded by Q value < 0.05, no clinical feature related to at least one genes.

  • No genes correlated to 'Time to Death', 'AGE', 'GENDER', 'PATHOLOGY.T', 'PATHOLOGY.N', 'TUMOR.STAGE', 'NEOADJUVANT.THERAPY', 'NUMBERPACKYEARSSMOKED', 'STOPPEDSMOKINGYEAR', 'TOBACCOSMOKINGHISTORYINDICATOR', and 'YEAROFTOBACCOSMOKINGONSET'.

- Results
- Overview of the results

Complete statistical result table is provided in Supplement Table 1

Table 1.  Get Full Table This table shows the clinical features, statistical methods used, and the number of genes that are significantly associated with each clinical feature at Q value < 0.05.

Clinical feature Statistical test Significant genes Associated with                 Associated with
Time to Death Cox regression test   N=0        
AGE Spearman correlation test   N=0        
GENDER t test   N=0        
PATHOLOGY T t test   N=0        
PATHOLOGY N Spearman correlation test   N=0        
TUMOR STAGE Spearman correlation test   N=0        
NEOADJUVANT THERAPY t test   N=0        
NUMBERPACKYEARSSMOKED Spearman correlation test   N=0        
STOPPEDSMOKINGYEAR Spearman correlation test   N=0        
TOBACCOSMOKINGHISTORYINDICATOR ANOVA test   N=0        
YEAROFTOBACCOSMOKINGONSET Spearman correlation test   N=0        
+ Methods & Data